Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States

James M. Paik, Pegah Golabi, Rakesh Biswas, Saleh Alqahtani, Chapy Venkatesan, Zobair M. Younossi – 4 April 2020 – In the United States, chronic viral hepatitis B and C (CHB and CHC), nonalcoholic fatty liver disease (NAFLD), and alcohol‐related liver disease (ALD) are the main causes of liver deaths attributable to hepatocellular carcinoma (HCC) and cirrhosis. Our aim was to assess the changes in the rates of mortality and years of potential life lost (YLL) for HCC and cirrhosis due to different liver diseases.

Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis

Tejasav S. Sehrawat, Juan P. Arab, Mengfei Liu, Pouya Amrollahi, Meihua Wan, Jia Fan, Yasuhiko Nakao, Elisa Pose, Amaia Navarro‐Corcuera, Debanjali Dasgupta, Chieh‐Yu Liao, Li He, Amy S. Mauer, Emma Avitabile, Meritxell Ventura‐Cots, Ramon A. Bataller, Arun J. Sanyal, Naga P. Chalasani, Julie K. Heimbach, Kymberly D. Watt, Gregory J. Gores, Pere Gines, Patrick S. Kamath, Douglas A. Simonetto, Tony Y. Hu, Vijay H. Shah, Harmeet Malhi – 4 April 2020

The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention‐to‐Treat Analysis

Giovanni B. Levi Sandri, Quirino Lai, Matteo Ravaioli, Stefano Di Sandro, Emanuele Balzano, Duilio Pagano, Paolo Magistri, Fabrizio Di Benedetto, Massimo Rossi, Salvatore Gruttadauria, Paolo De Simone, Giuseppe M.

Subscribe to